Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...] …
Articles by : Bella Czajkowski, National Correspondent
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...] …
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...] …
A key federal court decision to uphold Louisiana’s contact pharmacy law this week is drawing praise from provider groups and [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Eligible providers in Florida and North Carolina can now enroll in the 340B program outside of the formal enrollment period [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...] …
Editor’s Note: This article is available to all and is not behind the paywall. The first episode of 340B Report’s [...] …